Open AccessTrends in Use of Granulocyte Colony-Stimulating Factor Following Introduction of Biosimilars Among Adults With Cancer and Commercial or Medicare Insurance From 2014 to 2019
Author(s) -
ChingYu Wang,
Coy D. Heldermon,
Scott Martin Vouri,
Haesuk Park,
Sarah Wheeler,
Brian Hemendra Ramnaraign,
Nam H. Dang,
Joshua D. Brown
Publication year - 2021
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2021.33474
Subject(s) - medicine , febrile neutropenia , regimen , chemotherapy , biosimilar , chemotherapy regimen , neutropenia , oncology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom